4/18
01:00 am
tlsa
Medium
Report
4/16
09:18 am
tlsa
Tiziana says intranasal drug shows potential to ease Long COVID “brain fog” [Yahoo! Finance]
Medium
Report
Tiziana says intranasal drug shows potential to ease Long COVID “brain fog” [Yahoo! Finance]
4/16
07:00 am
tlsa
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
Low
Report
Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function
4/14
07:00 am
tlsa
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
High
Report
Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress
4/1
12:24 pm
tlsa
Tiziana Reports Promising Data Showing Nasal Anti-CD3 May Improve Age-Related Cognitive Decline [TheStreet.com]
Low
Report
Tiziana Reports Promising Data Showing Nasal Anti-CD3 May Improve Age-Related Cognitive Decline [TheStreet.com]
4/1
07:00 am
tlsa
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
Medium
Report
Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging
2/25
07:00 am
tlsa
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA
Low
Report
Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA
2/9
05:43 am
tlsa
While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership [Yahoo! Finance]
High
Report
While insiders own 43% of Tiziana Life Sciences Ltd (NASDAQ:TLSA), individual investors are its largest shareholders with 53% ownership [Yahoo! Finance]
1/20
11:15 am
tlsa
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab
Medium
Report
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab